In a cohort of 125 “at-risk” but cognitively unaffected PREVENT-AD individuals, CSF samples were used to measure protein levels of SERPINE1 and the AD biomarkers Aβ42, pTau181 and tTau. This evidence concerns the gene SERPINE1 and Alzheimer disease.